Bristol-Myers Squibb (BMY) Tops Q1 EPS by 9c; Boosts FY16 Outlook
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $44.70 -8.51%
Revenue Growth %: +5.3%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: +5.3%
Financial Fact:
Earnings Before Income Taxes: 1.56B
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of $0.74, $0.09 better than the analyst estimate of $0.65. Revenue for the quarter came in at $4.39 billion versus the consensus estimate of $4.19 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2016 EPS of $2.50-$2.60, versus the consensus of $2.40.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bristol-Myers Squibb (BMY) stock slips despite earnings beat
- USCB Financial Holdings, Inc. (USCB) Tops Q1 EPS by 2c
- SPS Commerce (SPSC) Tops Q1 EPS by 12c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
